Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Pharmacogenomics and prescription opioid.pdf.jpg](/retrieve/96d89889-1a3a-47f7-aff1-9f9fe20e0425/Pharmacogenomics%20and%20prescription%20opioid.pdf.jpg) | mar-2021 | Pharmacogenomics and prescription opioid use | Benjeddou, Mongi; Peiró, Ana | ![](/image/closedAccess.png) |
![Codeine and Tramadol use in athletes A potential for abuse.pdf.jpg](/retrieve/a8be4457-c089-4e2d-ba0c-38e2eebabfba/Codeine%20and%20Tramadol%20use%20in%20athletes%20A%20potential%20for%20abuse.pdf.jpg) | jun-2021 | Codeine and Tramadol Use in Athletes: A Potential for Abuse | Zandonai, Thomas; Escorial, Mónica; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib.pdf.jpg](/retrieve/629e64e1-340a-4667-89df-9ba3cc604a9d/Effect%20of%20Cytochrome%20P450%20and%20ABCB1%20Polymorphisms%20on%20Imatinib.pdf.jpg) | may-2020 | Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose
Administration to Healthy Subjects | Pena, María de los Ángeles; Muriel, Javier; Saiz Rodríguez, Miriam; Borobia, Alberto M.; Abad-Santos, Francisco; Frías, Jesús; Peiró, Ana | ![](/image/closedAccess.png) |
![Association between chronic pain medications.pdf.jpg](/retrieve/d3b43b36-3681-43bf-8658-45f8cb5d5815/Association%20between%20chronic%20pain%20medications.pdf.jpg) | jul-2021 | Association between chronic pain medications and the severity and mortality of COVID-19: Study protocol for a case-population study | Serrano Afonso, Ancor; Pérez hernández, Concepción; Ochoa Mazarro, Dolores; Román Martínez, Manuel; Failde Martínez, Inmaculada; Montes Pérez, Antonio; López Pais, Pablo; Cánovas Martínez, Luz; Revuelta Rizo, Miren; Padilla del Rey, María Luz; Peiró, Ana; Aberasturi Fueyo, Teresa; Margarit Ferrí, César; Rojo Rodríguez, Elena; Mendiola de la Osa, Agustín; Muñoz Martinez, Manuel José; Domínguez Bronchal, María Jesús; Herrero Trujillano, Manuel; Cid Calzada, José; Fabregat-Cid, Gustavo; Hernández-Cádiz, María José; Mareque Ortega, Manuel; Gómez-Caro Álvarez Palencia, Leticia; Mayoral Rojals, Víctor | ![](/image/openAccess.png) |
![The effect of benzodiazepines on exercise in healthy adult participants. A systematic review.pdf.jpg](/retrieve/afb119ed-51e4-49f3-8f89-8ff28a74247b/The%20effect%20of%20benzodiazepines%20on%20exercise%20in%20healthy%20adult%20participants.%20A%20systematic%20review.pdf.jpg) | 9-nov-2021 | The effect of benzodiazepines on exercise in healthy adult participants: A systematic review | Holgado, Darías; Manresa Rocamora, Agustin; Zamboni, Lorenzo; Lugoboni, Fabio; Peiró, Ana; Zandonai, Thomas | ![](/image/closedAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpg](/retrieve/8a3fbbc5-ffc9-46b8-b233-5a18818cb254/CYP2D6%20phenotypes%20and%20opioid%20metabolism.%20the%20path%20to%20personalised%20analgesia.pdf.jpg) | abr-2022 | CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia | Ballester, Purificación; Muriel, Javier; Peiró, Ana | ![](/image/closedAccess.png) |
![Sleep in autism A biomolecular approach to aetiology and treatment.pdf.jpg](/retrieve/7ff8b2c4-75c6-4cc0-98fb-6e7dc2fdee91/Sleep%20in%20autism%20A%20biomolecular%20approach%20to%20aetiology%20and%20treatment.pdf.jpg) | jul-2020 | Sleep in autism: A biomolecular approach to aetiology and treatment | Ballester, Purificación; Richdale, A.L.; Baker, E.K.; Peiró, Ana | ![](/image/closedAccess.png) |
![The challenge of detecting adverse events in adults with autism.pdf.jpg](/retrieve/d98d8190-390a-400b-b2d5-c2701c7e0b73/The%20challenge%20of%20detecting%20adverse%20events%20in%20adults%20with%20autism.pdf.jpg) | may-2021 | The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability | Ballester, Purificación; Espadas, Cristina; Londoño, Ana C.; Almenara, Susana; Aguilar, Víctor; Belda, César; Pérez, Enrique; Muriel, Javier; Peiró, Ana | ![](/image/openAccess.png) |